4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carboxamide phosphodiesterase-4 inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7342024
APP PUB NO 20060058316A1
SERIAL NO

10534582

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds represented by Formula (I): or a pharmaceutically acceptable salt thereof, are phosphodiesterase 4 inhibitors useful in the treatment of asthma and inflammation and useful for the enhancement of cognition ##STR00001##

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK FROSST CANADA LTD16711 TRANS-CANADA HWY KIRKLAND QUEBEC H9H 3L1

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aspiotis, Renee Montreal, CA 12 48
Dube, Daniel St. Lazare, CA 40 291
Dube, Laurence Pierrefonds, CA 10 40
Gallant, Michel Montreal, CA 39 311
Girard, Yves Ile-Bizard, CA 49 438
Lacombe, Patrick Montreal, CA 26 149
Macdonald, Dwight L'lle Bizard, CA 33 167

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation